NLRP3 and diabetic kidney disease: Encouragingly, both our team and other scholars have demonstrated the potent anti‐inflammatory effects of AP/PCC, which can inhibit Nlrp3‐mediated pyroptosis and ameliorate a variety of inflammatory disorders, including diabetic nephropathy and neuroinflammation, by reducing the levels of inflammatory factors, especially IL‐1β.26, 27, 49, 50, 51